Ampio Pharmaceuticals Inc (AMPE)
0.255
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Ampio Pharmaceuticals Max Drawdown (5Y): 99.97% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 99.97% |
| March 31, 2024 | 99.90% |
| February 29, 2024 | 99.81% |
| January 31, 2024 | 99.80% |
| December 31, 2023 | 99.78% |
| November 30, 2023 | 99.77% |
| October 31, 2023 | 99.70% |
| September 30, 2023 | 99.61% |
| August 31, 2023 | 99.61% |
| July 31, 2023 | 99.61% |
| June 30, 2023 | 99.61% |
| May 31, 2023 | 99.61% |
| April 30, 2023 | 99.61% |
| March 31, 2023 | 99.61% |
| February 28, 2023 | 99.61% |
| January 31, 2023 | 99.61% |
| December 31, 2022 | 99.61% |
| November 30, 2022 | 99.53% |
| October 31, 2022 | 99.51% |
| September 30, 2022 | 98.56% |
| August 31, 2022 | 97.94% |
| July 31, 2022 | 96.52% |
| June 30, 2022 | 96.16% |
| May 31, 2022 | 96.11% |
| April 30, 2022 | 95.40% |
| Date | Value |
|---|---|
| March 31, 2022 | 95.40% |
| February 28, 2022 | 95.40% |
| January 31, 2022 | 95.40% |
| December 31, 2021 | 95.40% |
| November 30, 2021 | 95.40% |
| October 31, 2021 | 95.40% |
| September 30, 2021 | 95.40% |
| August 31, 2021 | 95.40% |
| July 31, 2021 | 95.40% |
| June 30, 2021 | 95.40% |
| May 31, 2021 | 95.40% |
| April 30, 2021 | 95.40% |
| March 31, 2021 | 95.40% |
| February 28, 2021 | 95.40% |
| January 31, 2021 | 95.40% |
| December 31, 2020 | 95.40% |
| November 30, 2020 | 95.40% |
| October 31, 2020 | 95.40% |
| September 30, 2020 | 95.40% |
| August 31, 2020 | 95.40% |
| July 31, 2020 | 95.40% |
| June 30, 2020 | 95.40% |
| May 31, 2020 | 95.40% |
| April 30, 2020 | 95.40% |
| March 31, 2020 | 95.40% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
95.40%
Minimum
May 2019
99.97%
Maximum
Apr 2024
96.89%
Average
95.40%
Median
May 2019
Max Drawdown (5Y) Benchmarks
| NeuBase Therapeutics Inc | 99.84% |
| Tivic Health Systems Inc | -- |
| Oragenics Inc | 98.92% |
| Actinium Pharmaceuticals Inc | 97.29% |
| MAIA Biotechnology Inc | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -98.76 |
| Beta (5Y) | 2.139 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 103.5% |
| Historical Sharpe Ratio (5Y) | -0.7236 |
| Historical Sortino (5Y) | -1.257 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 48.15% |